Financial Analysis of Beximco Pharma
Introduction:
BEXIMCO Pharmaceuticals Limited’ belongs to BEXIMCO Group, the largest private sector industrial conglomerate in Bangladesh. Over the last thirty years the company was making good profit. In this paper, the last two years financial statement of BEXIMCO Pharmaceuticals Limited has been analyzed..
Company Profile of ‘BEXIMCO Pharmaceuticals Limited’:
BEXIMCO Pharmaceuticals Ltd. (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and currently producing more than 400 products in different dosage forms covering broader therapeutic categories which include antibiotics, antihypertensives, antidiabetics, antireretrovirals, anti asthma inhalers etc, among many others.
Ensuring access to quality medicines is the powerful aspiration that motivates more than 3000 employees of the organization, and each of them is guided by the same moral and social responsibilities the company values most.
Key Company Information:
Year of Establishment :: 1976
Country of Incorporation :: Bangladesh
Commercial Production :: 1980
Status :: Public Limited Company
Business Lines :: Manufacturing and marketing of pharmaceutical Finished Formulation Products, Large Volume Parenterals and Active Pharmaceutical Ingredients (APIs)
Main Country of operation :: Bangladesh
Overseas Offices & Associates :: Australia, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines, Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen
Financial Statements of the company:
|[pic] |
BEXIMCO Pharmaceuticals Limited’ belongs to BEXIMCO Group, the largest private sector industrial conglomerate in Bangladesh. Over the last thirty years the company was making good profit. In this paper, the last two years financial statement of BEXIMCO Pharmaceuticals Limited has been analyzed..
Company Profile of ‘BEXIMCO Pharmaceuticals Limited’:
BEXIMCO Pharmaceuticals Ltd. (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and currently producing more than 400 products in different dosage forms covering broader therapeutic categories which include antibiotics, antihypertensives, antidiabetics, antireretrovirals, anti asthma inhalers etc, among many others.
Ensuring access to quality medicines is the powerful aspiration that motivates more than 3000 employees of the organization, and each of them is guided by the same moral and social responsibilities the company values most.
Key Company Information:
Year of Establishment :: 1976
Country of Incorporation :: Bangladesh
Commercial Production :: 1980
Status :: Public Limited Company
Business Lines :: Manufacturing and marketing of pharmaceutical Finished Formulation Products, Large Volume Parenterals and Active Pharmaceutical Ingredients (APIs)
Main Country of operation :: Bangladesh
Overseas Offices & Associates :: Australia, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines, Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen
Financial Statements of the company:
|[pic] |